|
GB1555654A
(en)
|
1977-06-25 |
1979-11-14 |
Exxon Research Engineering Co |
Agricultural burner apparatus
|
|
US4065562A
(en)
|
1975-12-29 |
1977-12-27 |
Nippon Shinyaku Co., Ltd. |
Method and composition for reducing blood glucose levels
|
|
NO154918C
(no)
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
|
GB2020278B
(en)
|
1978-05-03 |
1983-02-23 |
Nippon Shinyaku Co Ltd |
Moranoline dervitives
|
|
JPS568318A
(en)
|
1979-06-28 |
1981-01-28 |
Janssen Pharmaceutica Nv |
Non oral long acting composition of haloperidol and bromperidol derivative
|
|
GB8311286D0
(en)
|
1983-04-26 |
1983-06-02 |
Searle & Co |
Carboxyalkyl peptide derivatives
|
|
EP0144290A3
(de)
|
1983-12-01 |
1987-05-27 |
Ciba-Geigy Ag |
Substituierte Aethylendiaminderivate
|
|
US5041441A
(en)
|
1988-04-04 |
1991-08-20 |
The Regents Of The University Of Michigan |
Method of chemotherapy using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol
|
|
JPH0416856A
(ja)
|
1990-05-10 |
1992-01-21 |
Canon Inc |
正帯電性非磁性トナー
|
|
JPH04140984A
(ja)
|
1990-10-02 |
1992-05-14 |
Canon Inc |
スチルビデオカメラ
|
|
RU2005102C1
(ru)
*
|
1991-06-21 |
1993-12-30 |
Институт геологии Карельского научного центра РАН |
Способ получени декоративного стекла
|
|
US5302609A
(en)
|
1992-12-16 |
1994-04-12 |
The Regents Of The University Of Michigan |
Treatment of diabetic nephropathy
|
|
US5399567A
(en)
|
1993-05-13 |
1995-03-21 |
Monsanto Company |
Method of treating cholera
|
|
ATE197672T1
(de)
|
1993-08-13 |
2000-12-15 |
Seikagaku Kogyo Co Ltd |
Arzneimittel gegen nervöse erkrankungen
|
|
JPH09508900A
(ja)
|
1994-02-02 |
1997-09-09 |
ザ リポソーム カンパニー、インコーポレーテッド |
薬理学的に活性な化合物及びリポソーム並びにそれらの使用方法
|
|
CN1152907A
(zh)
|
1994-06-10 |
1997-06-25 |
生化学工业株式会社 |
2-酰胺基丙醇化合物及其药物组合物
|
|
US5916911A
(en)
|
1995-09-20 |
1999-06-29 |
The Regents Of The University Of Michigan |
Amino ceramide--like compounds and therapeutic methods of use
|
|
US20030073680A1
(en)
|
1995-09-20 |
2003-04-17 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US6890949B1
(en)
|
1999-07-09 |
2005-05-10 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US6255336B1
(en)
|
1995-09-20 |
2001-07-03 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
WO2001004108A1
(en)
|
1999-07-09 |
2001-01-18 |
Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
JP3993908B2
(ja)
|
1995-12-08 |
2007-10-17 |
生化学工業株式会社 |
アミノアルコール誘導体及び該誘導体の製造方法
|
|
NO965193L
(no)
|
1995-12-08 |
1997-06-09 |
Seikagaku Kogyo Kk Seikagaku C |
Aminalkoholderivat og fremgangsmåte for fremstilling derav
|
|
JP4140984B2
(ja)
|
1995-12-20 |
2008-08-27 |
生化学工業株式会社 |
分化誘導作用を有する薬剤
|
|
US5972928A
(en)
*
|
1997-05-21 |
1999-10-26 |
Johns Hopkins University |
Methods for treatment of conditions associated with lactosylceramide
|
|
JP4036500B2
(ja)
|
1997-05-23 |
2008-01-23 |
生化学工業株式会社 |
アミノアルコール誘導体及びそれを含有する医薬
|
|
JP4176170B2
(ja)
|
1997-06-06 |
2008-11-05 |
生化学工業株式会社 |
アミノアルコール誘導体を含む医薬及び異常増殖性疾患治療薬
|
|
US6465488B1
(en)
|
1997-12-11 |
2002-10-15 |
Chancellor, Masters & Scholars Of The University Of Oxford |
Inhibition of glycolipid biosynthesis
|
|
WO2000006145A1
(en)
|
1998-07-27 |
2000-02-10 |
Johns Hopkins University |
Methods for treating conditions modulated by lactosylceramide
|
|
US6610703B1
(en)
|
1998-12-10 |
2003-08-26 |
G.D. Searle & Co. |
Method for treatment of glycolipid storage diseases
|
|
GB0100889D0
(en)
|
2001-01-12 |
2001-02-21 |
Oxford Glycosciences Uk Ltd |
Compounds
|
|
BR0012318A
(pt)
*
|
1999-07-09 |
2002-05-28 |
Univ Michigan |
Compostos semelhantes a amino ceramida e métodos terapêuticos de uso
|
|
US6407064B2
(en)
|
1999-12-06 |
2002-06-18 |
Seikagaku Corporation |
Aminoalcohol derivative and medicament comprising the same
|
|
JP5009459B2
(ja)
*
|
1999-12-06 |
2012-08-22 |
生化学工業株式会社 |
アミノアルコール誘導体及びそれを含有する医薬
|
|
US6235737B1
(en)
|
2000-01-25 |
2001-05-22 |
Peter Styczynski |
Reduction of hair growth
|
|
EP1284723A4
(en)
|
2000-04-19 |
2004-06-30 |
Borody Thomas J |
COMPILATIONS AND THERAPIES FOR HYPERLIPIDEMIA-ASSOCIATED DISEASES
|
|
EP1351924A2
(en)
|
2000-12-20 |
2003-10-15 |
Bristol-Myers Squibb Pharma Company |
Diamines as modulators of chemokine receptor activity
|
|
WO2002053528A1
(en)
|
2000-12-29 |
2002-07-11 |
Wyeth |
Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
|
|
US20040260099A1
(en)
|
2001-01-10 |
2004-12-23 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
WO2002062777A2
(en)
|
2001-01-10 |
2002-08-15 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US20020198240A1
(en)
|
2001-01-10 |
2002-12-26 |
Shayman James A. |
Amino ceramide - like compounds and therapeutic methods of use
|
|
US7148251B2
(en)
|
2001-01-10 |
2006-12-12 |
The Regents Of The University Of Michigan |
Amino ceramide-like compounds and therapeutic methods of use
|
|
ES2399323T3
(es)
|
2001-07-16 |
2013-03-27 |
Genzyme Corporation |
Síntesis de inhibidores de la UDP-glucosa:N-acilesfingosina glucosiltransferasa
|
|
US6835831B2
(en)
*
|
2001-11-26 |
2004-12-28 |
Genzyme Corporation |
Diastereoselective synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
|
|
GB0229931D0
(en)
|
2002-12-21 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
|
AU2002367266A1
(en)
*
|
2001-12-28 |
2003-07-24 |
Sumitomo Pharmaceuticals Company, Limited |
Disease markers for renal diseaes and utilization thereof
|
|
GEP20063909B
(en)
*
|
2002-01-22 |
2006-08-25 |
Warner Lambert Co |
2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d] PYRIMIDIN-7-ONES
|
|
EP1336411A1
(en)
|
2002-02-14 |
2003-08-20 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Compositions and methods for improving enzyme replacement therapy of lysosomal storage diseases
|
|
JP2003238410A
(ja)
|
2002-02-21 |
2003-08-27 |
Seibutsu Yuki Kagaku Kenkyusho:Kk |
インスリン抵抗性解除剤
|
|
US20060217560A1
(en)
|
2002-04-29 |
2006-09-28 |
Shayman James A |
Amino ceramide-like compounds and therapeutic methods of use
|
|
US6916802B2
(en)
|
2002-04-29 |
2005-07-12 |
Genzyme Corporation |
Amino ceramide-like compounds and therapeutic methods of use
|
|
AU2003246942B2
(en)
|
2002-07-17 |
2009-06-25 |
Idorsia Pharmaceuticals Ltd |
Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
|
|
KR20050021502A
(ko)
|
2002-07-17 |
2005-03-07 |
바이오겐 아이덱 엠에이 인코포레이티드 |
인터페론-β를 이용한 신부전증의 치료법
|
|
WO2004078194A1
(en)
|
2003-02-28 |
2004-09-16 |
Intermune, Inc. |
Interferon drug therapy for the treatment of viral diseases and liver fibrosis
|
|
GB0313678D0
(en)
|
2003-06-13 |
2003-07-16 |
Oxford Glycosciences Uk Ltd |
Novel compounds
|
|
EP1528056A1
(en)
|
2003-10-29 |
2005-05-04 |
Academisch Ziekenhuis bij de Universiteit van Amsterdam |
Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
|
|
PT1680112E
(pt)
|
2003-10-29 |
2011-03-24 |
Genzyme Corp |
N-(5-adamantano-1-il-metoxi-pentil)desoxinojirimicina ou um seu sal aceite na indústria farmacêutica para ser usado no tratamento da resistência à insulina
|
|
JP2007516294A
(ja)
|
2003-12-23 |
2007-06-21 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
炎症性の疾患または症状の予防および治療のための方法および組成物
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
JP5154218B2
(ja)
|
2004-03-16 |
2013-02-27 |
ネーデルランドセ オルガニサティエ フォール トエゲパスト−ナトールヴェテンシャッペリク オンデルゾエク ティエヌオー |
２型糖尿病、インスリン抵抗性及びメタボリック症候群の治療及び予防においてスフィンゴ脂質を使用する方法
|
|
EP1576894A1
(en)
|
2004-03-16 |
2005-09-21 |
Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO |
The use of sphingolipids in the treatment and prevention of type 2 diabetes mellitus, insulin resistance and Metabolic Syndrome
|
|
MXPA06012690A
(es)
|
2004-05-07 |
2007-01-16 |
Merck Patent Gmbh |
Gm3 sintasa como un objetivo terapeutico en complicaciones microvasculares de diabetes.
|
|
US20090111812A1
(en)
|
2004-06-14 |
2009-04-30 |
Musc Foundation For Research Development |
Methods for treating inflammatory disorders
|
|
EP1799258A4
(en)
|
2004-08-20 |
2009-07-22 |
Univ Johns Hopkins |
PROCESS FOR TREATING ANGIOGENESIS
|
|
WO2006053043A2
(en)
|
2004-11-10 |
2006-05-18 |
Genzyme Corporation |
Methods of treating diabetes mellitus
|
|
NZ556614A
(en)
*
|
2005-01-26 |
2010-10-29 |
Allergan Inc |
3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
|
|
US8389472B2
(en)
|
2005-08-19 |
2013-03-05 |
Amylin Pharmaceuticals, Llc |
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
|
|
HUE026057T2
(en)
|
2006-05-09 |
2016-05-30 |
Genzyme Corp |
Procedures for the Treatment of Fatty Liver Disease, which comprises inhibition of glycosphingolipid synthesis
|
|
WO2008011487A2
(en)
|
2006-07-19 |
2008-01-24 |
Allergan, Inc. |
L-benzyl-l-hydr0xy-2, 3-diamin0-propyl amines and 3-benzyl-3-hydroxy-2-amino-propionicacid amides for chronic pain
|
|
WO2008011478A2
(en)
|
2006-07-19 |
2008-01-24 |
Allergan, Inc. |
Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
|
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
|
TWI389895B
(zh)
|
2006-08-21 |
2013-03-21 |
Infinity Discovery Inc |
抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法
|
|
EP2117541A1
(en)
*
|
2007-02-09 |
2009-11-18 |
Irm Llc |
Compounds and compositions as channel activating protease inhibitors
|
|
EP2167485B1
(en)
*
|
2007-05-31 |
2015-09-30 |
Genzyme Corporation |
2-acylaminopropoanol-type glucosylceramide synthase inhibitors
|
|
EP2209473B1
(en)
|
2007-10-05 |
2017-11-22 |
Genzyme Corporation |
Method of treating polycystic kidney diseases with ceramide derivatives
|
|
WO2009117150A2
(en)
|
2008-03-20 |
2009-09-24 |
Genzyme Corporation |
Method of treating lupus with ceramide derivatives
|
|
US8389517B2
(en)
|
2008-07-28 |
2013-03-05 |
Genzyme Corporation |
Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
|
|
RU2578947C2
(ru)
|
2008-10-03 |
2016-03-27 |
Джензайм Корпорейшн |
Ингибиторы глюкозилцерамидсинтазы 2-ациламинопропанольного типа
|